Metabolism Books

Book Synopsis

Read more less

Book Synopsis

Read more less

Book SynopsisSince the birth of the dietary fibre hypothesis in the early 1970''s, research on this topic has been growing rapidly. However, though the remarkable number of experimental works, the role of fibre on human health is still uncompletely understood. The objective of this book is to synthesise the current knowledge on the physiological effects of dietary fibre in man by focusing on the mechanisms of action.

Read more less

Book SynopsisDesigned as reference material to increase knowledge of the human body. Beautiful full-colour illustrations help enhance understanding of the body or illness. Suitable for healthcare professions, patients, students, educators and parents.

Read more less

Book SynopsisBasierend auf Erfahrungswerten aus über 30.000 Operationen im Kaiserin-Elisabeth-Spital wird in dem Band die Schilddrüsenchirurgie dargestellt. Beschrieben werden die Entstehung des Wiener Behandlungszentrums, der Wandel von Diagnose und OP-Verfahren sowie die Verbesserung der Ergebnisse. Mit Anleitungen zur Schilddrüsenchirurgie, Skizzen und Fallbeispielen sowie fast 200 Abbildungen. Qualitätsindikatoren werden anhand von Grafiken und Tabellen veranschaulicht. Das Werk vermittelt wertvolle Anregungen für das Qualitätsmanagement in der Chirurgie.Table of ContentsI Überblick „Qualität“ – Die Ergebnisqualität als ein maßgeblicher Faktor im Krankenhaus II Ergebnisqualität in der Schilddrüsenchirurgie und BegriffsdefinitionenIII Ergebnisqualität am Kaiserin Elisabeth Spital als Teil des EFQM-Modells IV Die Entstehung eines Kompetenzzentrums – Wie das Kaiserin Elisabeth Spital zum „Kropfspital“ wurde V Die Jahre von 1918 bis 2008: 75.969 Schilddrüsenoperationen im Überblick VI Die Jahre von 1979 bis 2008: 30.142 Schilddrüsenoperationen –Diagnosen und Operationsstrategie im Wandel der ZeitMorbidität und Mortalität im internationalen Vergleich1. Der Anstieg der Operationsfrequenz der letzten 30 Jahre 2. Operationsindikation und Gestaltenwandel der klinisch-pathologischen Diagnosen und im 30-Jahreszeitraum 3. Das Schilddrüsenkarzinom – Epidemiologie und Gestaltenwandel -die Daten des Kaiserin Elisabeth Spitals im nationalen und internationalen Vergleich4. Die gutartige Struma – Operationsindikation und chirurgische Strategie im Wandel VII Operationsverfahren in der Schilddrüsenchirurgie1. Chirurgische Anatomie der Schilddrüse 2. Standardisierten Operationsverfahren an der Schilddrüse3. Kompartmentorientierte Lymphknotenchirurgie – Grundlagen 4. Entwicklung und Fortschritte der Schilddrüsenchirurgie von 1979 bis 2008 - Paradigmenwechsel in der Operationsstrategie und Wandel des Resektionsverfahrens VIII Ergebnisqualität Schilddrüsenchirurgie 1979 bis 2008 – die Datenlage - dokumentiert an 30.142 Patienten und 51.501 operierten Schilddrüsenlappen1. Qualitätsindikator Rekurrensparese – Stimmbandnervlähmung3. Qualitätsindikator Nachblutung 4. Qualitätsindikator Wundinfektion

Read more less

Book SynopsisThis handbook provides a step-by-step approach to using metabolic equations, from basic math principles to applying the equations to an exercise plan. Chapters focus separately on each equation, provide an easy-to-follow process of solving, and demonstrate the varied uses of the equation in clinical as well as fitness settings.Each chapter includes a set of problems that focus on real-world applications of the equation. Step-by-step problem solution explanations are provided at the end of each chapter. A comprehensive exam at the end of the book tests the reader''s skill in using the equations.Table of ContentsIntroductionMetabolic PrimerMathematical PrimerIntroduction to the ACSM Metabolic CalculationsWalking EquationRunning EquationLeg Cycle EquationArm Cycle EquationStepping EquationOther Modes of Cardiovascular ExerciseMetabolic Calculations: Application to Exercise TestingACSM Metabolic Calculations ProblemsACSM Metabolic Calculations: Multiple-Choice TestAppendices

Read more less

Book Synopsis Selected as a Doody's Core Title for 2022!Ideal for all health care professionals who evaluate, diagnose, treat, or refer patients with endocrine disease or disorders, Manual of Endocrinology and Metabolism, Fifth Edition , brings together nearly 150 global authorities who share their knowledge and expertise on endocrine disorders in children, adolescents, and adults. Using a concise outline format, this thoroughly updated manual presents clinical information and protocols needed in everyday practice, with an emphasis on diagnosis and treatment. Succinct chapters and an abundance of tables and diagrams make complex information easy to find and understand. Includes coverage of fundamental understandings and treatment modalities as well as recent therapies, new methods of treatment, new understandings of endocrine physiology, and new surgical approaches to disease states Covers evaluation, pathophysiology, management, and treatment at ev

Read more less

Book SynopsisThe metabolomics and systems biology approach to research can be applied to many disciplines. This book provides a solid introduction to medical metabolomics and systems biology, and demonstrates how they have been applied to studies in medicine and human health, including nutrition and pathogenic microorganisms. Following core themes of diagnosis, pathology and aetiology of disease, this book provides a reference for health care professionals interested in how to use metabolomics for medical research.Table of Contentsa: Foreword 1: An Introduction to Metabolomics and Systems Biology 2: Metabolomics in Neuroscience and Neurology 3: Cardiovascular Disease and Health 4: Chronic Obstructive Pulmonary Disease (COPD) and Metabolomics 5: In Search of New Biomarkers for Liver Diseases 6: Influences Shaping Digestive Health Explored Using Metabolomics 7: Applications of Metabolomics in the Study of Pathogenic Microorganisms and Their Effects on Human Health 8: Type 2 Diabetes Mellitus and The Metabolic Syndrome 9: Biomarkers of Skeletal Muscle Regulation, Metabolism and Dysfunction 10: Applications of Metabolomics in Cancer Research

Read more less

Book SynopsisObesity is one of the most relevant public health concerns today and it is now evident that body weight control is achieved through highly integrated physiological interactions like nutrient selection as well as being influenced by genetic and environmental factors. Moreover, energy balance regulation is a complex process aimed at maintaining constant energy stores. Presenting a detailed and comprehensive account of the roles of specific peptides in energy balance, food intake control and co-morbidities, this review provides a better understanding of the patho-physiology of energy balance and obesity.Table of ContentsSection 1: Central pathways involved in the control of food intake and energy expenditure 1: Orexigenic neuropeptides: Hypothalamic regulation of appetite 2: Anorexigenic peptides 3: Newcomers and supporting actors Section 2: Peripheral signals participating in energy homeostasis and obesity: associated alterations 4: The gut as a second brain 5: The adipo-hepato-insular axis in glucose homeostasis 6: Elements of the adipostat 7: Adipocytokines participating in the immune-stress response 8: Peptides involved in vascular homeostasis 9: Natriuretic peptides and other lipolytic peptides involved in the control of lipid mobilization Section 3: Integrative Perspectives 10: Hierarchy of neural pathways controlling energy homeostasis 11: Relevance of reward signals in the homeostatic control of energy balance 12: Overview of the Integrative physiology of adipose tissue in energy homeostasis 13: Is the energy homeostasis system inherently biased toward weight gain? A teleological molecular physiological and clinical view 14: Embracing complexity: The emergence of functional neuroimaging and other methodologies to study the role of the human brain in the pathophysiology of obesity. 15: Application of ""OMICS"" strategies to obesity research 16: Implications for the future of obesity management"

Read more less

Book Synopsis

Read more less

Book SynopsisA guided tour through the strange science of hormones and the age-old quest to control them.Trade Review"A rollicking history certain to get your intellectual and physiologic juices flowing. Adrenaline-tinged tales and hot flashes of history—just what the doctor ordered." -- Lisa Sanders, New York Times Magazine Diagnosis columnist"A sweeping, glorious story of hormones, threaded through with sex, suffering, neurology, biology, medicine and self-discovery, Randi Hutter Epstein’s book manages to excite the imagination as well as calm it. The story is grippingly told, and Epstein manages to bring a whole system of science alive to her reading public." -- Siddhartha Mukherjee, author of The Gene: An Intimate History"Hormones may be ringmasters of the bodily circus, controlling everything from sex to metabolic function, but in this invigorating history they become stars of the show." -- Nature"Congratulations to my friend @randihepstein on the publication of her book! I loved reading it and highly recommend it to anyone interested in public health or your own health!" -- Chelsea Clinton"I’m hitting up the public library for two. The first is Randi Hutter Epstein’s Aroused: The history of hormones and how they control just about everything (Norton), which I hope will answer the most banal of questions as I continue my reluctant march through midlife: What the hell is happening to me?" -- Jennie Erin Smith, Summer Books 2018 - Times Literary Supplement"The field of endocrinology, as this compelling history shows, has manifested extremes of ingenuity and hubristic error." -- The New Yorker"A well-written and informative book on the history of hormone research." -- The New York Times Book Review

Read more less

Book SynopsisThe instant New York Times bestseller.A groundbreaking method to master all types of diabetes by reversing insulin resistance. Current medical wisdom advises that anyone suffering from diabetes or prediabetes should eat a low-carbohydrate, high-fat diet. But in this revolutionary book, Cyrus Khambatta, PhD, and Robby Barbaro, MPH, rely on a century of research to show that advice is misguided. While it may improve short-term blood glucose control, such a diet also increases the long-term risk for chronic diseases like cancer, high blood pressure, high cholesterol, chronic kidney disease, and fatty liver disease.The revolutionary solution is to eat a low-fat plant-based whole-food diet, the most powerful way to reverse insulin resistance in all types of diabetes: type 1, type 1.5, type 2, prediabetes, and gestational diabetes.As the creators of the extraordinary and effective Mastering Diabetes Method, Khambatta and Barbaro lay out a

Read more less

Book SynopsisHuman health issues relating to amino acids are extremely broad and include metabolic disorders of amino acid metabolism as well as their presence in food and use as supplements. This book covers the biochemistry of amino acid metabolism in the context of health and disease. It discusses their use as food supplements, in clinical therapy and nutritional support and focuses on major recent developments, highlighting new areas of research that will be needed to sustain further interest in the field.Table of ContentsPART I: ENZYMES AND METABOLISM 1: Glutamate Dehydrogenase 2: Aminotransferases 3: Arginase 4: Bypassing the Endothelial L-Arginine-Nitric-Oxide Pathway: Effects of Dietary Nitrite and Nitrate on Cardiovascular Function 5: Histidine Decarboxylase 6: Glutamate Decarboxylase 7: Glutaminase 8: D-Serine and Serine Racemase in Retina 9: Tryptophan Hydroxylase 10: Methionine Metabolism PART II: DYNAMICS 11: Amino Acid Transport Across Each Side of the Blood-Brain Barrier 12: Inter-Organ Fluxes of Amino Acids 13: Cellular Adaptation to Amino Acid Availability: Mechanisms Involved in the Regulation of Gene Expression PART III: NUTRITION 14: Endogenous Amino Acids at the Terminal Ileum of the Adult Human 15: Metabolic Availability of Amino Acids in Food Proteins: New Methodology 16: Amino Acid Requirements: Quantitative Estimates 17: Amino Acid Supplements and Muscular Performance 18: Amino Acids in Clinical and Nutritional Support: Glutamine in Duchenne Muscular Dystrophy 19: Adverse Effects 20: The Umami Taste of Glutamate PART IV: HEALTH 21: Homocysteine Status: Factors Affecting and Health Risks 22: Modified Amino Acid-Based Molecules: Accumulation and Health Implications 23: Phenylketonuria: Newborn Identification Through to Adulthood 24: Principles of Rapid Tryptophan Depletion and its use in Research on Neuropsychiatric Disorders 25: Excitatory Amino Acids in Neurological and Neurodegenerative Disorders 26: Efficacy of L-DOPA Therapy in Parkinson's Disease 27: Amino Acid Profiles for Diagnostic Applications PART V: CONCLUSIONS 28: Emergence of a New Momentum

Read more less

Book SynopsisThe COVID-19 pandemic caused by the SARS-CoV-2 virus has affected nearly every country and territory in the world. Although worldwide vaccination efforts have reduced the risk of serious disease outcomes, disparities in distribution have led to multiple waves of SARS-CoV-2 outbreaks and the emergence of variants of concern, some of which have enhanced infectivity and ability to evade existing vaccines. Hence there is an increasing interest in understanding the evolution of viruses like SARS-CoV-2, as well as improving our capacity to effectively current and manage future pandemics.This new volume reviews the most effective omic techniques for increasing our understanding of COVID-19, to improve diagnostics, prognostics, and genomic surveillance, and to facilitate development of effective treatments and vaccines. Chapters are written by an international team of experts and explore methods in the areas of genomics, transcriptomics, proteomics, and metabolomics. Techniques used to assess physiological function at the molecular level and artificial intelligence approaches used for more effective validation and translation of biomarker candidates into clinical use are also discussed. This book is an excellent resource for researchers studying biomarkers, virology, metabolic diseases, and infectious diseases, as well as clinical scientists, physicians, drug company scientists, and healthcare workers. Table of Contents1. LC-MS Analysis of Serum and Plasma to Identify Circulating Biomarkers of SARS-CoV-2 Infection2. Mass Spectrometry Analyses Combined with Machine Learning to Identify Robust Biomarkers for COVID-19 Disease3. Selective Reaction Monitoring Mass Spectrometry Methods for Establishing a Panel of COVID-19 Biomarkers4. Chip-Based Assays for Multiplexed Analysis of SARS-CoV-2 Viral Infection5. Screening of Metabolic Profiles of Serum Metabolites in COVID-19 Patients6. Proteomic Techniques in Models of SARS-CoV-2 Infection7. Multiplex Immunoassay Approaches to Study the Cytokine Storm Effect8. Proteomic Methods for the Study of Organ Failure Associated with Severe COVID-19 Disease Courses9. Screening of Natural Products for COVID-19 Treatment using Multiplex Biomarker Readouts10. Multiplex Lateral Flow Antigen and Antibody Tests for Diagnosis and Surveillance of COVID-19 Disease11. Genomic Surveillance Techniques to Monitor SARS-CoV-2 Variants of Concern12. Multiplex Quantitative PCR Approaches for Diagnosis and Tracking of SARS-CoV-2 Variants13. Lipidomic Analysis of Fatty Acids as Potential New Biomarkers and Targets for Improved Treatment of COVID-19 Disease14. Multiplex Omic Methods for Screening and Triaging COVID-19 Patients According to Disease Severity15. Point-of-Care Techniques to Establish Risk of COVID-19 Disease Outcomes16. Multiplex Vaccination Approaches for Keeping Pace with Emerging SARS-CoV-2 Variants of Concern17. The Combined use of Artificial Intelligence and Circulating Molecular Profiles to Identify Prognostic Markers of COVID-19 Disease

Read more less

Book SynopsisMETABOLIC SYNDROME A comprehensive look at the fight against the metabolic syndrome epidemic Increasing risk of cardiovascular disease and diabetes, the metabolic syndrome is a world health problem that demands attention from all levels of the health care industry. Metabolic Syndrome: Underlying Mechanisms and Drug therapies extensively covers the metabolic syndrome with an emphasis on drug discovery efforts, providing a context of molecular mechanisms and drug pharmacology for pharmaceutical scientists. The book starts by examining the physiology of metabolic tissues under normal and disease states, followed by discussions of metabolic diseases and clinical complications. The development of drug therapies based on emerging science is then covered extensively. In addition, there is an in-depth look into the metabolic pathways and dysfunctions in metabolic disease, especially type 2 diabetes and lipid disorders. Finally, a chapter is devoted to past succTrade Review"This is an outstanding addition to the current body of work on the metabolic syndrome. I thought it particularly exhaustive in its review of the literature, making it an excellent resource for scouring the primary literature, and found the duality of current and future treatment approaches particularly insightful." (Doody's, 21 October 2011) "The book offers a comprehensive and in-depth view of energy metabolism, metabolic tissues and pathways, molecular mechanism-based drug discovery and clinical implications." (Pharmiweb, 1 March 2011)Table of ContentsIntroduction ix Minghan Wang Contributors xi Part One The Physiology of Metabolic Tissues Under Normal and Disease States 1. Gut as an Endocrine Organ: the Role of Nutrient Sensing in Energy Metabolism 3 Minghan Wang 2. Central Glucose Sensing and Control of Food Intake and Energy Homeostasis 29 Lourdes Mounien and Bernard Thorens 3. Abnormalities in Insulin Secretion in Type 2 Diabetes Mellitus 53 Taly Meas and Pierre-Jean Guillausseau 4. Adipokine Production by Adipose Tissue: A Novel Target for Treating Metabolic Syndrome and its Sequelae 73 Vanessa DeClercq, Danielle Stringer, Ryan Hunt, Carla G. Taylor, and Peter Zahradka 5. Hepatic Metabolic Dysfunctions in Type 2 Diabetes: Insulin Resistance and Impaired Glucose Production and Lipid Synthesis 133 Ruojing Yang 6. Energy Metabolism in Skeletal Muscle and its Link to Insulin Resistance 157 Minghan Wang Part Two Metabolic Diseases and Current Therapies 7. Mechanisms and Complications of Metabolic Syndrome 179 Minghan Wang 8. Emerging Therapeutic Approaches for Dyslipidemias Associated with High LDL and Low HDL 199 Margrit Schwarz and Jae B. Kim 9. Mechanism of Action of Niacin: Implications for Atherosclerosis and Drug Discovery 235 Devan Marar, Shobha H. Ganji, Vaijinath S. Kamanna, and Moti L. Kashyap 10. Current Antidiabetic Therapies and Mechanisms 253 Minghan Wang Part Three Drug Targets for Antidiabetic Therapies 11. GLP-1 Biology, Signaling Mechanisms, Physiology, and Clinical Studies 281 Remy Burcelin, Cendrine Cabou, Christophe Magnan, and Pierre Gourdy 12. Dipeptidyl Peptidase IV Inhibitors for Treatment of Diabetes 327 C.H.S. McIntosh, S.-J. Kim, R.A. Pederson, U. Heiser, and H.-U. Demuth 13. Sodium Glucose Cotransporter 2 Inhibitors 359 Margaret Ryan and Serge A. Jabbour 14. Fibroblast Growth Factor 21 as a Novel Metabolic Regulator 377 Radmila Micanovic, James D. Dunbar, and Alexei Kharitonenkov 15. Sirtuins as Potential Drug Targets for Metabolic Diseases 391 Qiang Tong 16. 11β-Hydroxysteroid Dehydrogenase Type 1 as a Therapeutic Target for Type 2 Diabetes 423 Clarence Hale and David J. St. Jean, Jr. 17. Monoclonal Antibodies for the Treatment of Type 2 Diabetes: A Case Study with Glucagon Receptor Blockade 459 Hai Yan, Wei Gu, and Murielle Veniant-Ellison Part Four Lessons Learned and Future Outlook 18. Drug Development for Metabolic Diseases: Past, Present and Future 471 Minghan Wang Index 489

Read more less

Book SynopsisFIVE STARS from Doody's Star Ratings™ This essential guide encompasses the core principles of Manual Lymph Drainage and Complete Decongestive Therapy for a wide range of pathologies across the age continuum. Key elements from the prior edition are incorporated, such as color-coded sections for anatomy, physiology, and pathophysiology. Advances in the field are reflected in expanded chapters and efficacy meta-analyses, updates on genetics, refinements in manual compression, and new insights on fat disorders and edema. Key highlights in fourth edition More than 140 new color images, over 30 new tables, and updated ICD-10 codes Expanded discussion of lipedema and related conditions such as Dercum's and Madelung's diseases Surgical approaches such as vascularized lymph node transfer, anastomosis and bypass techniques, suction assisted protein lipectomy, and combined and staged lymphedema operations Wound care options for edema and advanced venous disease Integration of conventional therapies and techniques in collaboration with surgeons who perform specialized lymphatic procedures Tips and guidance for growing numbers of home care focused practitioners who encounter lymphedema and related edemas in patients Management of garments including fit, functionality, and patient independence Rare pediatric syndromes and adaption of CDT for children Expanded discussion of sequential intermittent pneumatic compression including contraindications and usages in lymphedema management This is a must-have resource on the diagnosis, treatment, and management of lymphedema and lymphatic insufficiency. Its unique practicality will enable educators to teach techniques and clinicians to adeptly incorporate a wide range of treatment strategies into practice.Table of Contents1 Anatomy 2 Physiology 3 Pathology 4 Complete Decongestive Therapy 5 Treatment 6 Administration

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book SynopsisThis book is a comprehensive guide to endocrinology for clinicians and trainees. Beginning with an overview of the endocrine system, the text then describes the chemistry and mechanism of hormones and their clinical significance. The following sections discuss the role of different organs in the endocrine system, including glands, the pancreas, and gonads. The next chapters cover hormones in other organs such as the gastrointestinal tract, liver, kidney and heart. The book concludes with discussion on endocrine tumours and growth factors. Key points Comprehensive guide to endocrinology for clinicians and trainees In depth discussion on chemistry and mechanism of hormones Examines role of different organs in the endocrine system Includes chapters on endocrine tumours and growth factors Table of Contents Introduction Hormone Action Hypothalamus Pituitary Gland Thyroid Gland Adrenal Gland Hormones Regulation Calcium Metabolism Pancreas Gonads Adipose Tissue Pineal Gland Gastrointestinal Tract Hormones Hormones from Liver Hormones from Kidney Hormones from Heart Retinoic Acid Prostaglandins Nitric Oxide Endocrine Tumours Growth Factors

Read more less

Book SynopsisThe authoritative reference to bone diseases and disorders of mineral metabolism, revised and updated Now in its ninth edition,The Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolismoffers anupdated and comprehensive guide tobone and mineral health. Since it was first published 30 years ago, the Primer has become the leading reference on the topic. With contributions from noted experts, the text explores basic biological factors of healthy development and disease states and makes the information accessible for clinical interventions. The ninth edition provides concise coverage of the widest possible spectrum of metabolic bone diseases and disorders of mineral metabolism. The new edition of this invaluable reference expands coverage and includes the most recent developments in the field that help to strengthen its usefulness and ensure that thePrimer on the Metabolic Bone Diseases and Disorders of Mineral Metabolismmaintains its place as the pre-eminent referencTable of ContentsContributors xi Preface to the Ninth Edition of the Primer:John P. Bilezikian xxiv About ASBMR xxv President’s Preface Michael J. Econs xxvi About the Companion Website xxvii Section I Molecular and Cellular Determinants of Bone Structure and Function 1Section Editor Karen Lyons 1 Early Skeletal Morphogenesis in Embryonic Development 3Yingzi Yang 2 Endochondral Ossification 12Courtney M. Karner and Matthew J. Hilton 3 Local and Circulating Osteoprogenitor Cells and Lineages 20Naomi Dirckx and Christa Maes 4 Osteoblasts Function, Development, and Regulation 31Elizabeth W. Bradley, Jennifer J. Westendorf, Andre J. van Wijnen, and Amel Dudakovic 5 Osteocytes 38Lynda F. Bonewald 6 Osteoclast Biology and Bone Resorption 46Hiroshi Takayanagi 7 Signal Transduction Cascades Controlling Osteoblast Differentiation 54David J.J. de Gorter, Gonzalo Sánchez‐Duffhues, and Peter ten Dijke 8 The TGF‐β Superfamily in Bone Formation and Maintenance 60Ce Shi and Yuji Mishina 9 Recent Developments in Understanding the Role of Wnt Signaling in Skeletal Development and Disease 68Zhendong A. Zhong, Nicole J. Ethen, and Bart O. Williams 10 Mechanotransduction in Bone Formation and Maintenance 75Whitney A. Bullock, Lilian I. Plotkin, Alexander G. Robling, and Fredrick M. Pavalko 11 The Composition of Bone 84Adele L. Boskey and Pamela G. Robey 12 Assessment of Bone Mass, Structure, and Quality in Rodents 93Jeffry S. Nyman and Deepak Vashishth 13 Skeletal Healing Cellular and Molecular Determinants 101Alayna E. Loiselle and Michael J. Zuscik 14 Biomechanics of Fracture Healing 108Elise F. Morgan, Amira I. Hussein, and Thomas A. Einhorn Section II Skeletal Physiology 115Section Editor Ego Seeman 15 Human Fetal and Neonatal Bone Development 117Tao Yang, Monica Grover, Kyu Sang Joeng, and Brendan Lee 16 Skeletal Growth a Major Determinant of Bone’s Structural Diversity in Women and Men 123Ego Seeman 17 Racial Differences in the Acquisition and Age‐related Loss of Bone Strength 131Shane A. Norris, Marcella D. Walker, Kate Ward, Lisa K. Micklesfield, and John M. Pettifor 18 Calcium, Vitamin D, and Other Nutrients During Growth 135Tania Winzenberg and Graeme Jones 19 Mechanical Loading and the Developing Skeleton 141Mark R. Forwood 20 Pregnancy and Lactation 147Christopher S. Kovacs and Henry M. Kronenberg 21 Menopause and Age‐related Bone Loss 155Carlos M. Isales and Ego Seeman Section III Mineral Homeostasis 163Section Editors David Goltzman and Harald Jüppner 22 Regulation of Calcium Homeostasis 165Line Vautour and David Goltzman 23 Magnesium Homeostasis 173Aliya Aziz Khan, Asiya Sbayi, and Karl Peter Schlingmann 24 Fetal Calcium Metabolism 179Christopher S. Kovacs 25 FGF23 and the Regulation of Phosphorus Metabolism 187Kenneth E. White and Michael J. Econs 26 Gonadal Steroids 194Stavros C. Manolagas and Maria Schuller Almeida 27 Parathyroid Hormone 205Thomas J. Gardella, Robert A. Nissenson, and Harald Jüppner 28 Parathyroid Hormone‐Related Protein 212John J. Wysolmerski and T. John Martin 29 Calcium‐Sensing Receptor 221Geoffrey N. Hendy 30 Vitamin D Production, Metabolism, Action, and Clinical Requirements 230Daniel D. Bikle, John S. Adams, and Sylvia Christakos Section IV Investigation of Metabolic Bone Diseases 241Section Editors Douglas C. Bauer and Klaus Engelke 31 Techniques of Bone Mass Measurement in Children with Risk Factors for Osteoporosis 243Nicola J. Crabtree and Leanne M. Ward 32 Standard Techniques of Bone Mass Measurement in Adults 252E. Michael Lewiecki, Paul D. Miller, and Nelson B. Watts 33 Advanced Techniques of Bone Mass Measurements and Strength in Adults 260Kyle K. Nishiyama, Enrico Dall’Ara, and Klaus Engelke 34 Magnetic Resonance Imaging of Bone 272Sharmila Majumdar 35 Trabecular Bone Score 277Barbara C. Silva and William D. Leslie 36 Reference Point Indentation 287Adolfo Diez‐Perez and Joshua N. Farr 37 Biochemical Markers of Bone Turnover in Osteoporosis 293Pawel Szulc, Douglas C. Bauer, and Richard Eastell 38 Scintigraphy and PET in Metabolic Bone Disease 302Lorenzo Nardo, Paola A. Erba, and Benjamin L. Franc 39 Bone Histomorphometry in Clinical Practice 310Robert R. Recker and Carolina Aguiar Moreira 40 Diagnosis and Classification of Vertebral Fracture 319James F. Griffith and Harry K. Genant 41 FRAX Assessment of Fracture Risk 331John A. Kanis, Eugene V. McCloskey, Nicholas C. Harvey, and William D. Leslie Section V Genetics of Bone 341Section Editor Rajesh V. Thakker 42 Introduction to Genetics 343Paul J. Newey, Michael P. Whyte, and Rajesh V. Thakker 43 Animal Models Genetic Manipulation 351Karen Lyons 44 Animal Models Allelic Determinants for Bone Mineral Density 359J. H. Duncan Bassett, Graham R. Williams, and Robert D. Blank 45 Transcriptional Profiling for Genetic Assessment 367Aimy Sebastian and Gabriela G. Loots 46 Approaches to Genetic Testing 373Christina Jacobsen, Yiping Shen, and Ingrid A. Holm 47 Human Genome‐Wide Association Studies 378Douglas P. Kiel, Emma L. Duncan, and Fernando Rivadeneira 48 Translational Genetics of Osteoporosis From Population Association to Individualized Assessment 385Bich Tran, Jacqueline R. Center, and Tuan V. Nguyen Section VI Osteoporosis 393Section Editors Paul D. Miller, Socrates E. Papapoulos, and Michael R. McClung 49 Osteoporosis an Overview 395Michael R. McClung, Paul D. Miller, and Socrates E. Papapoulos 50 The Epidemiology of Osteoporotic Fractures 398Nicholas C. Harvey, Elizabeth M. Curtis, Elaine M. Dennison, and Cyrus Cooper 51 Fracture Liaison Service 405Piet Geusens, John A. Eisman, Andrea Singer, and Joop van den Bergh 52 Sex Steroids and the Pathogenesis of Osteoporosis 412Matthew T. Drake and Sundeep Khosla 53 Juvenile Osteoporosis 419Francis H. Glorieux and Craig Munns 54 Transplantation Osteoporosis 424Peter R. Ebeling 55 Premenopausal Osteoporosis 436Adi Cohen and Elizabeth Shane 56 Osteoporosis in Men 443Eric S. Orwoll and Robert A. Adler 57 Bone Stress Injuries 450Stuart J. Warden and David B. Burr 58 Inflammation‐Induced Bone Loss in the Rheumatic Diseases 459 Ellen M. Gravallese and Steven R. Goldring 59 Glucocorticoid‐Induced Osteoporosis 467Kenneth Saag and Robert A. Adler 60 Human Immunodeficiency Virus and Bone 474Michael T. Yin and Todd T. Brown 61 Effects on the Skeleton from Medications Used to Treat Nonskeletal Disorders 482Nelson B. Watts 62 Diabetes and Fracture Risk 487Serge Ferrari, Nicola Napoli, and Ann Schwartz 63 Obesity and Skeletal Health 492Juliet Compston 64 Sarcopenia and Osteoporosis 498Gustavo Duque and Neil Binkley 65 Management of Osteoporosis in Patients with Chronic Kidney Disease 505Paul D. Miller 66 Other Secondary Causes of Osteoporosis 510Neveen A. T. Hamdy and Natasha M. Appelman‐Dijkstra 67 Exercise for Osteoporotic Fracture Prevention and Management 517Robin M. Daly and Lora Giangregorio 68 Prevention of Falls 526Heike A. Bischoff‐Ferrari 69 Nutritional Support for Osteoporosis 534Connie M. Weaver, Bess Dawson‐Hughes, Rene Rizzoli, and Robert P. Heaney 70 Estrogens, Selective Estrogen Receptor Modulators, and Tissue‐Selective Estrogen Complex 541Tobias J. de Villiers 71 Bisphosphonates for Postmenopausal Osteoporosis 545Andrea Giusti and Socrates E. Papapoulos 72 Denosumab 553Aline Granja Costa, E. Michael Lewiecki, and John P. Bilezikian 73 Parathyroid Hormone and Abaloparatide Treatment for Osteoporosis 559Felicia Cosman and Susan L. Greenspan 74 Combination Anabolic and Antiresorptive Therapy for Osteoporosis 567Joy N. Tsai and Benjamin Z. Leder 75 Strontium Ranelate and Calcitonin 573Leonardo Bandeira and E. Michael Lewiecki 76 Adverse Effects of Drugs for Osteoporosis 579Bo Abrahamsen and Daniel Prieto‐Alhambra 77 Orthopedic Principles of Fracture Management 588Manoj Ramachandran and David G. Little 78 Adherence to Osteoporosis Therapies 593Stuart L. Silverman and Deborah T. Gold 79 Cost‐Effectiveness of Osteoporosis Treatment 597Anna N.A. Tosteson 80 Future Therapies 603Michael R. McClung Section VII Metabolic Bone Diseases 611Section Editors Suzanne M. Jan de Beur and Peter R. Ebeling 81 Approach to Parathyroid Disorders 613John P. Bilezikian 82 Primary Hyperparathyroidism 619Shonni J. Silverberg, Francisco Bandeira, Jianmin Liu, Claudio Marcocci, and Marcella D. Walker 83 Familial States of Primary Hyperparathyroidism 629Andrew Arnold, Sunita K. Agarwal, and Rajesh V. Thakker 84 Non‐Parathyroid Hypercalcemia 639Mara J. Horwitz 85 Hypocalcemia Definition, Etiology, Pathogenesis, Diagnosis, and Management 646Anne L. Schafer and Dolores M. Shoback 86 Hypoparathyroidism 654Tamara Vokes, Mishaela R. Rubin, Karen K. Winer, Michael Mannstadt, Natalie E. Cusano, Harald Jüppner, and John P. Bilezikian 87 Pseudohypoparathyroidism 661Agnès Linglart, Michael A. Levine, and Harald Jüppner 88 Disorders of Phosphate Homeostasis 674Mary D. Ruppe and Suzanne M. Jan de Beur 89 Rickets and Osteomalacia 684Michaël R. Laurent, Nathalie Bravenboer, Natasja M. Van Schoor, Roger Bouillon, John M. Pettifor, and Paul Lips 90 Pathophysiology and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder 695Mark R. Hanudel, Sharon M. Moe, and Isidro B. Salusky 91 Disorders of Mineral Metabolism in Childhood 705Thomas O. Carpenter and Nina S. Ma 92 Paget Disease of Bone 713Julia F. Charles, Ethel S. Siris, and G. David Roodman 93 Epidemiology, Diagnosis, Evaluation, and Treatment of Nephrolithiasis 721Murray J. Favus and David A. Bushinsky 94 Immobilization and Burns Other Conditions Associated with Osteoporosis 730William A. Bauman, Christopher Cardozo, and Gordon L. Klein Section VIII Cancer and Bone 737Section Editors Theresa Guise and G. David Roodman 95 Mechanisms of Osteolytic and Osteoblastic Skeletal Lesions 739G. David Roodman and Theresa Guise 96 Clinical and Preclinical Imaging in Osseous Metastatic Disease 743Siyang Leng and Suzanne Lentzsch 97 Metastatic Tumors and Bone 752Julie A. Sterling and Rachelle W. Johnson 98 Myeloma Bone Disease and Other Hematological Malignancies 760Claire M. Edwards and Rebecca Silbermann 99 Osteogenic Osteosarcoma 768Yangjin Bae, Huan‐Chang Zeng, Linchao Lu, Lisa L. Wang, and Brendan Lee 100 Skeletal Complications of Breast and Prostate Cancer Therapies 775Catherine Van Poznak and Pamela Taxel 101 Bone Cancer and Pain 781Denis Clohisy and Lauren M. MacCormick 102 Radiotherapy‐Induced Osteoporosis 788Laura E. Wright 103 Skeletal Complications of Childhood Cancer 793Manasa Mantravadi and Linda A. DiMeglio 104 Medical Prevention and Treatment of Bone Metastases 799Catherine Handforth, Stella D’Oronzo, and Janet Brown 105 Radiotherapy of Skeletal Metastases 809Srinivas Raman, K. Liang Zeng, Oliver Sartor, Edward Chow, and Øyvind S. Bruland 106 Concepts and Surgical Treatment of Metastatic Bone Disease 816Kristy Weber and Scott L. Kominsky Section IX Sclerosing and Dysplastic Bone Diseases 823Section Editor Michael P. Whyte 107 Sclerosing Bone Disorders 825Michael P. Whyte 108 Fibrous Dysplasia 839Michael T. Collins, Alison M. Boyce, and Mara Riminucci 109 The Osteochondrodysplasias 848Fabiana Csukasi and Deborah Krakow 110 Ischemic and Infiltrative Disorders of Bone 853Michael P. Whyte 111 Tumoral Calcinosis – Dermatomyositis 861Nicholas J. Shaw 112 Genetic Disorders of Heterotopic Ossification: Fibrodysplasia Ossificans Progressiva and Progressive OsseousHeteroplasia 865Frederick S. Kaplan, Robert J. Pignolo, Mona Al Mukaddam, and Eileen M. Shore 113 Osteogenesis Imperfecta 871Joan C. Marini 114 Fibrillinopathies Skeletal Manifestations of Marfan Syndrome and Marfan‐Related Conditions 878Gary S. Gottesman and Michael P. Whyte 115 Hypophosphatasia and Other Enzyme Deficiencies Affecting the Skeleton 886Michael P. Whyte Section X Oral and Maxillofacial Biology and Pathology 891Section Editor Laurie McCauley 116 Craniofacial Morphogenesis 893Erin Ealba Bumann and Vesa Kaartinen 117 Development and Structure of Teeth and Periodontal Teeth 901Petros Papagerakis and Thimios Mitsiadis 118 Genetic Craniofacial Disorders Affecting the Dentition 911Yong‐Hee Patricia Chun, Paul H. Krebsbach, and James P. Simmer 119 Pathology of the Hard Tissues of the Jaws 918Paul C. Edwards 120 Osteonecrosis of the Jaw 927Sotirios Tetradis, Laurie McCauley, and Tara Aghaloo 121 Alveolar Bone Homeostasis in Health and Disease 933Chad M. Novince and Keith L. Kirkwood 122 Oral Manifestations of Metabolic Bone Diseases 941Erica L. Scheller, Charles Hildebolt, and Roberto Civitelli 123 Dental Implants and Osseous Healing in the Oral Cavity 949Takashi Matsuura and Junro Yamashita Section XI Integrative Physiology of the Skeleton 957Section Editors Mone Zaidi and Clifford J. Rosen 124 Integrative Physiology of the Skeleton 959Clifford J. Rosen and Mone Zaidi 125 The Hematopoietic Niche and Bone 966Stavroula Kousteni, Benjamin J. Frisch, Marta Galan‐Diez, and Laura M. Calvi 126 Adipocytes and Bone 974Clarissa S. Craft, Natalie K. Wee, and Erica L. Scheller 127 The Vasculature and Bone 983Marie Hélène Lafage‐Proust and Bernard Roche 128 Immunobiology and Bone 992Roberto Pacifici and M. Neale Weitzmann 129 Cellular Bioenergetics of Bone 1004Wen‐Chih Lee and Fanxin Long 130 Endocrine Bioenergetics of Bone 1012Patricia F. Ducy and Gerard Karsenty 131 Central Neuronal Control of Bone Remodeling 1020Hiroki Ochi, Paul Baldock, and Shu Takeda 132 Peripheral Neuronal Control of Bone Remodeling 1028Katherine J. Motyl and Mary F. Barbe 133 The Pituitary–Bone Axis in Health and Disease 1037Mone Zaidi, Tony Yuen, Wahid Abu‐Amer, Peng Liu, Terry F. Davies, Maria I. New, Harry C. Blair, Alberta Zallone, Clifford J. Rosen, and Li Sun 134 Neuropsychiatric Disorders and the Skeleton 1047Madhusmita Misra and Anne Klibanski 135 Interactions Between Muscle and Bone 1055Marco Brotto Index 1063

Read more less

Book SynopsisSince cardiovascular (heart and blood vessel) disease is the leading cause of death for adults in developed countries, many medical studies focus on treating or preventing heart disease and stroke. The metabolic syndrome, a collection of unhealthy body measurements and abnormal laboratory test results, may identify persons at high risk for developing cardiovascular disease. Aggressive lifestyle modification and possible use of medications to treat the conditions that make up the metabolic syndrome may reduce a person''s chances of developing heart disease or stroke. The metabolic syndrome has also been called syndrome X or insulin resistance syndrome.

Read more less

Book SynopsisInsulin resistance (IR) and elevated blood pressure are two key features of the metabolic syndrome, which play an important role in the development of secondary cardiovascular complications. In this book, the effects of insulin resistance on the various vasoactive pathways are explored, which affect the equilibrium between vascular relaxation and constriction. Furthermore, the interaction between oestrogen, testosterone and insulin signalling-dependent changes in vascular reactivity and blood pressure are discussed. Also addressed in this book are the mechanisms underlying reciprocal relationships between insulin secretion, insulin resistance and inflammation in the pathological state and in its subsequent improvement. Moreover, the current concepts in understanding the underlying risk factors contributing to insulin resistance are examined, focusing on the role of magnesium deficiency that emerges as potential pathogenic key related with decreasing insulin sensitivity. In addition, it is widely accepted that metabolic syndrome is related to cardiovascular disease and that insulin resistance is one of the causes of metabolic syndrome. The authors discuss thiazolidinediones (TZDs), a class of antidiabetes agents, as a means to improve endothelial dysfunction, prevent atherosclerosis, and significantly reduce the risk of cardiovascular disease.

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book SynopsisThe literature concerning muscle Glycogenoses reflects a world-wide interest which has been greatly intensified, mainly over the last ten years. To a large extent, this renewed interest is due to recent advances in diagnosing and treating the Lysosomal disease named Glycogenosis II or Pompe disease (GSD II). The new therapeutic approaches must induce us to make a great effort in order to better diagnose, treat and follow correctly the patients with Pompe disease. This book is a comprehensive text which covers all of the aspects regarding this disease, from pathogenic to clinical and therapeutic features.

Read more less

Book SynopsisThis book follows an up to date authoritative style on the subject of parathyroid glands and their disorder. This book seeks to expand the horizon of parathyroid hormone use and provides in depth information on surgical techniques for managing its disorder. There are four sections on anatomy, function, disorder and treatment. The first three show how these areas are interconnected and the fourth on techniques for managing parathyroid disease. While short enough to be read as a treatise on parathyroid glands it is also authoritative enough to be used as a reference text.

Read more less

Book SynopsisThe literature concerning muscle Glycogenoses reflects a world-wide interest which has been greatly intensified, mainly over the last ten years. To a large extent, this renewed interest is due to recent advances in diagnosing and treating the Lysosomal disease named Glycogenosis II or Pompe disease (GSD II). The new therapeutic approaches must induce us to make a great effort in order to better diagnose, treat and follow correctly the patients with Pompe disease. This book is a comprehensive text which covers all of the aspects regarding this disease, from pathogenic to clinical and therapeutic features.

Read more less

Book SynopsisInsulin stimulates the uptake of glucose in several target tissues, including skeletal muscle and adipose tissue, thereby contributing to the decline in the blood glucose level. In this book, the authors present current research in the study of the regulation, signalling pathways and health implications of glucose uptake. Topics include glucose uptake and transport regulation; the mechanisms that contribute to glucose homeostasis; expression and regulation of neuronal glucose transporters in health and disease; role for the microvasculature in glucose uptake in skeletal muscle; implications of diabetes on sperm glucose uptake and metabolism; the beneficial role of estrogen signalling in glucose homeostasis and energy expenditure; glucose uptake and androgen responsiveness of prostate cancer cells; regulation of intestinal glucose uptake by leptin; and the Ras superfamily of small GTP-binding proteins in glucose transporter type 4-mediated glucose uptake in insulin-responsive tissues.

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book SynopsisThis text presents a compilation of topics that have been taught at Metabolic University (MU), an interactive, didactic educational program that has trained over 600 metabolic dietitians/nutritionists, physicians, nurses and genetic counselors. This book was created in 2014 for the metabolic community. The 1st edition contains only subject matter covered at Metabolic University; therefore, it is not a comprehensive treatise on Inherited Metabolic Disorders (IMD) but rather a text on the most frequently encountered challenges in IMD nutrition. Each chapter in the book highlights principles of nutrition management, how to initiate a diet, and biomarkers to monitor the diet. Recognizing that there are variations in practice, this book addresses that the key to management lies in the understanding how the inactivity of an enzyme in a metabolic pathway determines which components of the diet must be restricted and which must be supplemented as well as the monitoring of appropriate biomarkers to make diet adjustments and ensure the goals of therapy are met The 2nd edition is an updated and more extensive version covering the nutrition management of IMD, and covers a wide range of these disorders, including phenylketonuria and other aminoacidopathies, organic acidemias, urea cycle disorders, fatty acid oxidation disorders, galactosemia and glycogen storage diseases. Guidance is also provided on laboratory evaluations and biochemical testing and monitoring. Topics such as newborn screening for IMD, as well as nutrition management during pregnancy and transplantation, are also addressed. In addition, current medical management therapies is included.Table of ContentsBackground: Introduction to Genetics.- Expanded Newborn Screening for Inherited Metabolic Diseases.- Nutrition Education.- Pathophysiology of Inherited Metabolic Disease.- Metabolic Intoxication Syndrome in a Newborn.- Anabolism: Practical Strategies.- Protein Requirements in Inherited Metabolic Diseases.- Laboratory Evaluations in Inherited Metabolic Diseases. Aminoacidopathies: Phenyketonuria: Phenylalanine Neurotoxicity.- Phenylketonuria: The Diet Basics.- Understanding Large Neutral Amino Acids and the Blood Brain Barrier.- Tetrahydrobiopterin Therapy in Phenylketonuria.- Maternal Phenylketonuria.- Homocystinuria: Diagnosis and Management.- Nutrition Management of Urea Cycle Disorders.- Nutrition Management of Maple Syrup Urine Disease. Organic Acidemias: Organic Acidemias.- Glutaric Acidemia Type 1: Diagnosis and Management.- Nutrition Management of Glutaric Acidemia Type 1.- Nutrition Management of Propionic Acidemia and Methylmalonic Acidemia.- Nutrition Management during Pregnancy: Maple Syrup Urine Disease, Propionic Acidemia and Urea Cycle Disorders. Fatty Acid Oxidation Disorders: Fatty Acid Oxidation Disorders.- Nutrition Studies in Long Chain Fatty Acid Oxidation Disorders: Diet Composition and Monitoring.- Nutrition Management of Fatty Acid Oxidation Disorders. Disorders of Carbohydrate Metabolism: Nutrition Management of Galactosemia.- Glycogen Storage Disease.- Nutrition Management of Glycogen Storage Disease Type 1.

Read more less

Book SynopsisSeit Langem die erste Neuerscheinung zum Thema in deutscher Sprache, vereint das Werk die Subdisziplinen pädiatrische Endokrinologie und Diabetologie. Zwei Fachgebiete, die, trotz aller Eigenständigkeit, alleine schon durch die Weiterbildungsordnung zusammenwachsen. Die Autoren legen bei der Darstellung der Grundlagen sowie sämtlicher Krankheitsbilder großen Wert auf Verständlichkeit und Praxistauglichkeit. Die Herausgeber haben ein hochkarätiges Autorenteam versammelt und bürgen für Aktualität, Qualität und verlässliche Informationen.Trade Review Table of ContentsSektion 1: Grundlagen der Endokrinologie.- Physiologie der Hormonsynthese und -wirkung bei Kindern und Jugendlichen.- Embryologie, Wachstum und Entwicklung.- Molekulare und genetische Zusammenhänge in der pädiatrischen Endokrinologie.- Genetisch diagnostizierbare Krankheiten in der pädiatrischen Endokrinologie.- Sektion II: Spezielle Untersuchungsmethoden.- Klinische Untersuchung in der pädiatrischen Endokrinologie.- Grundlagen der Hormonbestimmung in der pädiatrischen Endokrinologie.- Testverfahren in der pädiatrischen Endokrinologie.- Sektion III: Umgang mit chronisch kranken Kindern und Jugendlichen.- Psychologische und pädagogische Elemente der Langzeitbehandlung bei Kindern und Jugendlichen mit chronischen Erkrankungen.- Endokrinologische Langzeitfolgen in der pädiatrischen Onkologie.- Sektion IV: Insulinsekretion und –wirkung.- Physiologie und Pathophysiologie der Insulinsekretion.- Hyperinsulinismus.- Diabetesformen bei Kindern und Jugendlichen.- Hypoglykämie bei Kindern und Jugendlichen.- Diabetische Ketoazidose bei Kindern und Jugendlichen.- Diabetes mellitus Typ 1 bei Kindern und Jugendlichen: Stoffwechselkontrolle und Folgeerkrankungen.- Diabetes mellitus Typ 1 bei Kindern und Jugendlichen: Ernährung und Medikamente.- Diabetes mellitus Typ 1 bei Kindern und Jugendlichen: Praxis der Insulininjektions- und Pumpentherapie.- Diabetes mellitus Typ 1 bei Kindern und Jugendlichen: Assoziierte Erkrankungen.- Sektion V: Energiebilanz.- Zentrale Regulation des Körpergewichtes.- Endokrine Störungen bei Kindern und Jugendlichen mit Adipositas.- Fettgewebe als endokrines Organ.- Braunes Fettgewebe: Energiebilanz und Thermoregulation.- Diagnostik der Adipositas bei Kindern und Jugendlichen.- Sektion VI: Endokrinologie der Entwicklung: Wachstum und Pubertät.- Störungen des Wachstums.- Störungen der Geschlechtsreife.- Endokrinologie des Neonaten.- Sektion VII: Organbezogene endokrinologische Erkrankungen.- Hypothalamus und Hypophyse: Anatomie, Physiologie und Erkrankungen.- Schilddrüse: Biochemische und physiologische Grundlagen.- Erworbene Hypothyreose.- Hyperthyreose bei Kindern und Jugendlichen.- Schilddrüsenneoplasien bei Kindern und Jugendlichen.- Angeborene Schilddrüsenerkrankungen bei Neugeborenen und Kleinkindern.- Embryologie und Anatomie der Nebenniere und Hormone der Nebennierenrinde.- Primäre Nebenniereninsuffizienz bei Kindern und Jugendlichen.- Nebennierenüberfunktion bei Kindern und Jugendlichen.- Hormone und Erkrankungen des Nebennierenmarks bei Kindern und Jugendlichen.- Knochenerkrankungen bei Kindern und Jugendlichen.- Endokrine Störungen des Mineralhaushaltes bei Kindern und Jugendlichen.- Störungen der Geschlechtsentwicklung.- Endokrine Störungen der Nierenfunktion und des Wasserhaushalts bei Kindern und Jugendlichen.- Sektion VIII: Referenzwerte pädiatrische Endokrinologie.- Referenzwerte pädiatrische Endokrinologie: Anthropometrische Parameter.- Referenzwerte pädiatrische Endokrinologie: Äußeres Genitale.- Referenzwerte pädiatrische Endokrinologie: Inneres Genitale.- Referenzwerte pädiatrische Endokrinologie: Schilddrüsenvolumen.- Referenzwerte pädiatrische Endokrinologie: Blutdruck.- Referenzwerte pädiatrische Endokrinologie: Endokrinologische Parameter

Read more less